
Upgrade Alert: Why Ideaya Biosciences (IDYA) Just Earned a ‘Buy’ Rating from Zacks – A Fun and Quirky Exploration!
IDYA’s Upgraded Zacks Rank: A Buying Opportunity Hey there, curious cat! I’ve got some scintillating news for you that’s bound to make your investment portfolio purr with joy. IDEAYA Biosciences (IDYA), the biotech company that’s been making waves in the healthcare industry, has been upgraded to a Zacks Rank #2, or a “Buy” rating. Now,…